EAU Podcasts
European Association of Urology
Episodes
Prof. Dasgupta and Assoc. Prof. Vásquez talk about the crucial role of mentorship and peer supportMarch 31, 2024
Prof. Somani and Ass. Prof. Gandaglia navigate between academia and clinical practiceMarch 24, 2024
Dr. Tailly and Dr. Sedelaar discuss work - well-being balance, and is it possible?March 17, 2024
Special series on RCC: Beyond first-line treatment strategies for mRCC with Dr. Mari and Dr. CiccareseMarch 10, 2024
Special series on RCC: First-line treatment strategies for mRCC with Dr. Mari and Dr. MarandinoMarch 03, 2024
ASCO GU24 special: Prof. Christophe Hennequin on GETUG-AFU 18 trial resultsFebruary 25, 2024
Special series on RCC: Role of cytoreductive nephrectomy for mRCC with Assist. Prof. Mari and Prof. BadaniFebruary 18, 2024
ASCO GU24 special: Prof. Michael Hofman talks about a novel CA IX-targeting peptideFebruary 14, 2024
ASCO GU24 special: Prof. Nizar Tannir shares CheckMate 214 resultsFebruary 11, 2024
ASCO GU24 special: Dr. Kim Chi discusses CONTACT-2 resultsFebruary 07, 2024
ASCO GU24 special: Assoc. Prof. Barata discusses the results of KEYNOTE-564 and CheckMate-914 February 04, 2024
ASCO GU24 special: Dr. Andrea Apolo shares AMBASSADOR resultsJanuary 31, 2024
Dr. Srikala Sridhar talks about PET imaging on staging of MIBCJanuary 14, 2024
Dr. Nic an Riogh discusses bladder outlet obstruction in womenJanuary 10, 2024
UROONCO RCC take home message for 2023December 27, 2023
Special series: Assoc. Prof. Şener and Dr. Pietropaolo talk about networking and building professional relationships in urologyDecember 17, 2023
Special series: Dr. Seguí-Moya talks with Prof. Brookman-May about preparing for a job interviewDecember 10, 2023
Special series: Dr. Rai and Dr. Kamphuis talk about preparing and keeping your CV updatedDecember 03, 2023
Special series: Ms. Moreno-Fontela and Assoc. Prof. Kasivisvanathan discuss the significant transition after residencyNovember 26, 2023
Prof. James Catto (GB) shares results of THOR-2 cohort 1 studyNovember 12, 2023
Dr. Agarwal shares LITESPARK-013 results: Optimal dose of belzutifan is 120mgNovember 08, 2023
Prof. Roberto Iacovelli: Drug interruptions in mRCC IO-TKI (Avelumab and axitinib) is safe and may reduce toxicity and cost for the treatmentNovember 01, 2023
Prof. Albiges shares LITESPARK-005 study results: Belzutifan improves PFS in pretreated mRCC patientsOctober 29, 2023
ESMO 2023 special: Dr. Van Der Heijden talks about the phase 3 CheckMate 901 trial resultsOctober 24, 2023
ESMO 2023 special: Prof. Powles shares positive KEYNOTE-A39 trial resultsOctober 22, 2023